Simon J Little

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering of 89,333,920 of its Class A ordinary shares, which included an…

Davis Polk is advising Reliance Industries Limited in connection with its agreement to establish a joint venture to be held 51% by RIL and 49% by an affiliate of BP plc. The joint venture…

Davis Polk is advising Nuvei Corporation in connection with its $889 million recommended cash offer to acquire the entire share capital of SafeCharge International Group Limited. Nuvei has…

Davis Polk advised Comcast Corporation on its $27 billion SEC-registered debt offering of three tranches of LIBOR-based floating-rate notes and nine tranches of fixed-rate notes with…

Davis Polk advised an ad hoc group of prepetition senior secured lenders in connection with the successful chapter 11 restructuring of Expro International Group Holdings Limited and certain…

Davis Polk advised ContourGlobal plc in connection with its initial public offering. The IPO comprised a primary offering of 122,399,020 new ordinary shares raising net proceeds of…

Davis Polk is advising Natura Cosméticos S.A. in connection with the proposed acquisition of The Body Shop group. Following an extensive review of the strategic options for The Body Shop to…

Davis Polk advised Technip S.A. on the closing of its combination with FMC Technologies, Inc. The transaction to form TechnipFMC plc, the new U.K. combined entity, was implemented through a…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 65,550,000 Class A ordinary shares of Ensco plc. Included in the shares are 8,550,000…